NDC 16729-0114-11 1

Etoposide 20 mg/mL Vial [Toposar] 2024-07-12

Supplier Accord Healthcare Inc.
Availability Status ASHP Shortage + QS Availability Issues (2024-07-12)
Status Description

QuicksortRx has identified an availability disruption across multiple channels, and ASHP has published an active drug shortage for this product. See their website for more information.

Quicksort Status Availability Issues Detected (2024-07-12)
ASHP Status ASHP Shortage Declared (2024-02-01)
QUMI Product Code secpgp2 (QuicksortRx Universal Medication Identifier)

NDC Package Count Supplier Description Status Updated
00143-9512-01
1 Hikma Pharmaceuticals USA Inc. Etoposide 20 mg/mL Vial [Toposar] No Availability Issues Detected
63323-0104-50
1 Fresenius Kabi USA, LLC Etoposide 20 mg/mL Vial [Toposar] No Availability Issues Detected
68001-0265-27
1 BluePoint Laboratories Etoposide 20 mg/mL Vial [Toposar] No Availability Issues Detected

QUMI Codes

QUMI Code Route Strength Form NDC Count Description
j8c7hkk Injectable 250 mg Vial 1 Etoposide 20 mg/mL Vial
k35rra1 Oral 50 mg Oral Capsule 1 Etoposide 50 mg Oral Capsule
tppqbxx Injectable 500 mg Vial 4 Etoposide 20 mg/mL Vial
w88p38j Injectable 100 mg Vial 6 Etoposide 20 mg/mL Vial

Previous Status Status Start Date Status End Date
ASHP Shortage + QS Availability Issues 2024-07-12 Current
No Availability Issues Detected 2024-07-12

RXCUI: 310248
Dosage Form: Vial
Dosage Route: INJECTABLE
Strength: 1000
Measure: mg
ANDA: ANDA074513
Generic Description: ETOPOSIDE
DEA: